Soleno Therapeutics, Inc. (SLNO) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 94.6M | 91.73M | 66.02M | 32.66M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 1.2M | 863K | 1.14M | 696K | 0 | 0 | 0 | 494K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | 1.27% | 0.94% | 1.73% | 2.13% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | 93.41M | 90.87M | 64.88M | 31.96M | 0 | 0 | 0 | -494K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Margin % | 98.73% | 99.06% | 98.27% | 97.87% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | - | - | 6569.84% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 61.64M | 50.44M | 42.77M | 38.49M | 45.74M | 59.12M | 80.21M | 22.74M | 23.48M | 13.91M | 10.38M | 8.62M | 8.47M | 5.61M | 6.24M | 6.78M | 5.77M | 3M | 8.29M | 11.09M |
| OpEx % of Revenue | 65.16% | 54.98% | 64.79% | 117.85% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 50.37M | 40.88M | 33.75M | 28.24M | 29.26M | 37.3M | 49.2M | 10.39M | 8.47M | 4.14M | 3.32M | 3.17M | 2.85M | 2.4M | 2.33M | 2.47M | 2.64M | 2.6M | 2.77M | 2.46M |
| SG&A % of Revenue | 53.24% | 44.56% | 51.13% | 86.47% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 11.27M | 9.56M | 8.4M | 9.15M | 13.52M | 21.49M | 30.14M | 12.34M | 14.6M | 8.69M | 6.04M | 5.14M | 5.32M | 3.81M | 3.77M | 3.7M | 3.99M | 3.73M | 4.97M | 5.59M |
| R&D % of Revenue | 11.92% | 10.42% | 12.73% | 28.01% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 614K | 1000K | 1000K | 327K | 877K | 0 | 401K | 1000K | 1000K | 313K | 299K | -602K | 132K | 616K | -858K | -1000K | 551K | 1000K |
| Operating Income | 31.76M | 40.43M | 22.11M | -6.53M | -45.74M | -59.12M | -80.21M | -23.23M | -23.48M | -13.91M | -10.38M | -8.62M | -8.47M | -5.61M | -6.24M | -6.78M | -5.77M | -3M | -8.29M | -11.09M |
| Operating Margin % | 33.57% | 44.08% | 33.48% | -19.98% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | 169.44% | 168.39% | 127.56% | 71.91% | -94.86% | -324.99% | -672.61% | -169.41% | -177.19% | -147.95% | -66.51% | -27.2% | -46.7% | -86.94% | 24.75% | 38.85% | -163.05% | 62.28% | -5.46% | 0.96% |
| EBITDA | 32.28M | 40.94M | 22.61M | -6.02M | -45.24M | -58.61M | -79.71M | -22.74M | -22.98M | -13.42M | -9.89M | -8.13M | -7.98M | -5.12M | -5.74M | -6.29M | -5.28M | -2.51M | -7.79M | -10.6M |
| EBITDA Margin % | 34.12% | 44.63% | 34.24% | -18.44% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | 171.35% | 169.85% | 128.36% | 73.51% | -96.82% | -336.73% | -705.82% | -179.53% | -188.07% | -162.03% | -72.24% | -29.38% | -51.09% | -104.15% | 26.32% | 40.66% | -154.75% | 66.41% | -5.78% | 1.03% |
| D&A (Non-Cash Add-back) | 514K | 509K | 502K | 502K | 504K | 503K | 500K | 494K | 490K | 489K | 490K | 489K | 490K | 488K | 492K | 492K | 492K | 492K | 492K | 490K |
| EBIT | 31.76M | 44.71M | 27.4M | -3.33M | -42.41M | -49.98M | -79.33M | -23.23M | -21.4M | -12.83M | -9.36M | -8.31M | -8.17M | -6.21M | -6.1M | -6.16M | -6.63M | -6.33M | -7.74M | -8.05M |
| Net Interest Income | 3.63M | 3.78M | 3.91M | 1.82M | 1.97M | 3.37M | 3.6M | 3.01M | 2.08M | 2.14M | 174K | 147K | 113K | 125K | 101K | 52K | 22K | 34K | 34K | 41K |
| Interest Income | 4.93M | 5.13M | 5.3M | 3.19M | 3.33M | 3.37M | 3.6M | 3.01M | 2.08M | 2.14M | 174K | 147K | 113K | 125K | 101K | 52K | 22K | 34K | 34K | 41K |
| Interest Expense | 1.29M | 1.35M | 1.39M | 1.38M | 1.36M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 3.15M | 2.93M | 3.91M | 1.82M | 1.97M | 3.13M | 3.6M | 1.38M | 2.08M | 2.61M | -479K | 148K | 113K | 124K | 103K | 54K | 49K | 173K | 146K | 97K |
| Pretax Income | 34.91M | 43.36M | 26.01M | -4.71M | -43.77M | -55.98M | -76.62M | -21.85M | -21.4M | -11.3M | -10.86M | -8.47M | -8.36M | -5.49M | -6.13M | -6.72M | -5.72M | -2.83M | -8.14M | -10.99M |
| Pretax Margin % | 36.9% | 47.27% | 39.4% | -14.42% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 3.54M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 10.13% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | 31.38M | 43.36M | 26.01M | -4.71M | -43.77M | -55.98M | -76.62M | -21.85M | -21.4M | -11.3M | -10.86M | -8.47M | -8.36M | -5.49M | -6.13M | -6.72M | -5.72M | -2.83M | -8.14M | -10.99M |
| Net Margin % | 33.17% | 47.27% | 39.4% | -14.42% | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 171.68% | 177.45% | 133.95% | 78.46% | -104.57% | -395.59% | -605.42% | -157.86% | -156.08% | -105.91% | -77.12% | -26.02% | -45.98% | -93.99% | 24.67% | 38.8% | 36.07% | 0.84% | 4.74% | -48.81% |
| Net Income (Continuing) | 31.38M | 43.36M | 26.01M | -4.71M | -43.77M | -55.98M | -76.62M | -21.85M | -21.4M | -11.3M | -10.86M | -8.47M | -8.36M | -5.49M | -6.13M | -6.72M | -5.72M | -2.83M | -8.14M | -10.99M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | 0.59 | 0.80 | 0.47 | -0.09 | -0.95 | -1.27 | -1.83 | -0.57 | -0.59 | -0.43 | -0.95 | -0.81 | -0.88 | -0.58 | -0.65 | -0.72 | -1.07 | -0.53 | -1.53 | -2.10 |
| EPS Growth % | 162.11% | 162.99% | 125.68% | 83.63% | -61.02% | -195.35% | -92.63% | 29.63% | 32.95% | 25.86% | -46.15% | -12.5% | 17.76% | -9.43% | 57.52% | 65.71% | 35.15% | 11.67% | 7.27% | 12.5% |
| EPS (Basic) | 0.60 | 0.96 | 0.49 | -0.09 | -0.95 | -1.27 | -1.83 | -0.57 | -0.59 | -0.43 | -0.95 | -0.81 | -0.88 | -0.58 | -0.65 | -0.72 | -1.07 | -0.53 | -1.53 | -2.10 |
| Diluted Shares Outstanding | 53.07M | 54.33M | 54.92M | 50.48M | 46.18M | 43.92M | 41.88M | 38.63M | 36.21M | 26.35M | 11.44M | 10.42M | 9.45M | 9.44M | 9.42M | 9.34M | 5.33M | 5.33M | 5.32M | 5.32M |
| Basic Shares Outstanding | 52.09M | 53.18M | 53.33M | 50.48M | 46.18M | 43.92M | 41.88M | 38.63M | 36.21M | 26.35M | 11.44M | 10.42M | 9.45M | 9.44M | 9.42M | 9.34M | 5.33M | 5.33M | 5.32M | 5.32M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |